Company Filing History:
Years Active: 2019
Title: Olga Ivanovna Lavrik: Innovator in Molecular Biology
Introduction
Olga Ivanovna Lavrik is a prominent inventor based in Novosibirsk, Russia. She has made significant contributions to the fields of molecular biology, biochemistry, and biotechnology. Her work focuses on developing compounds that exhibit inhibitory effects on specific enzymes, which can have important implications for medical research and treatment.
Latest Patents
Olga holds a patent for a compound known as 2-acetyl-6-(2-(2-(4-bromobenzylidene)hydrazinyl)thiazole-4-yl)-3,7,9-trihydroxy-8,9b-dimethyldibenzo[b,d]furan-1(9bh)-one. This compound is a hydrazine-thiazole derivative of usnic acid and is designed to inhibit the action of the human tyrosyl-DNA-phosphodiesterase 1 enzyme. The technical result of her invention is an increase in the inhibitory action towards this enzyme, which is crucial for various biological processes. The patent includes 1 independent claim, 2 figures, and 3 examples.
Career Highlights
Throughout her career, Olga has worked with several organizations, including Innovative Pharmacology Research LLC (iPhar) and the Society with Limited Liability "Innovative Pharmacology Research" (iPhar). Her experience in these companies has allowed her to advance her research and contribute to the field significantly.
Collaborations
Olga has collaborated with notable colleagues, including Olga Anatolyevna Luzina and Alexandra Leonidovna Zakharenko. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Olga Ivanovna Lavrik is a distinguished inventor whose work in molecular biology and biotechnology continues to influence the field. Her innovative approaches to enzyme inhibition hold promise for future medical advancements.